Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Disc Medicine Q2 EPS $(1.58) Misses $(1.13) Estimate

Author: Benzinga Newsdesk | August 07, 2025 07:36am
Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.58) per share which missed the analyst consensus estimate of $(1.13) by 39.58 percent. This is a 53.4 percent decrease over losses of $(1.03) per share from the same period last year.

Posted In: IRON


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist